apotheek Maes
Activeapotheek Maes has been active since 2005 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €86k and a net result of €78k. Equity is growing by ~6.1% per year across the filed fiscal years. Its solvency ranks better than 20% of 10310 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
Checked score
Score 2025
61
/ 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability80▼-2
Solvency35=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.6%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €5k at 30 days acceptable
Liquidity tight (current ratio 1.14 against 1.21 in 2024; short-term debt: 59.9% and cash: 17.3% of total assets), and 89.7% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
10.3%
Return on assets
9.3%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 20% of 10310 sector peers (2025).
NBB · sector comparisonPosition among 10310 sector peers
Solvency
better than 20%
← weakest
strongest →
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-08-2026, 28 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
28 d late
2024
61 d late
2023
30 d late
2022
32 d late
2021
5 d early
2020
31 d late
2019
59 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
19-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€86k▲ 3.1%
2024 · €83k
2018: €50k
2019: €59k
2020: €68k
2021: €74k
2022: €77k
2023: €77k
2024: €83k
2018 → 2025
Total assets
€831k▼ 0.1%
2024 · €833k
2018: €837k
2019: €837k
2020: €812k
2021: €763k
2022: €792k
2023: €856k
2024: €833k
2018 → 2025
Net result
€78k▼ 9.8%
2024 · €86k
2018: €42k
2019: €24k
2020: €39k
2021: €46k
2022: €33k
2023: €50k
2024: €86k
2018 → 2025
Working capital
€68k▼ 28.9%
2024 · €96k
2018: €-58k
2019: €158k
2020: €153k
2021: €150k
2022: €140k
2023: €120k
2024: €96k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€74k-€77k▲ 4.4%€77k=€83k▲ 7.8%€86k▲ 3.1%
Operating result€61k-€52k▼ 14.5%€61k▲ 16.5%€97k▲ 58.7%€90k▼ 6.7%
Net result€46k-€33k▼ 27.8%€50k▲ 50.4%€86k▲ 71.9%€78k▼ 9.8%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 7% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €831k
Fixed assets
€266k▼ 7.2%
Current assets
€566k▲ 3.6%
Equity and liabilities €831k
Equity
€86k▲ 3.1%
Debt
€746k▼ 0.5%
The debt ratio falls from 90.0% to 89.7%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€111k▼
2024 · €117k
Cash flow
€98k▼
2024 · €107k
Solvency
10.3%▲
2024 · 10.0%
Current ratio
1.14▼
2024 · 1.21
Quick ratio
0.89▼
2024 · 0.93
Debt / equity
8.70▼
2024 · 9.01
ROE
90.4%▼
2024 · 103.4%
ROA
9.3%▼
2024 · 10.3%
Interest coverage
8.69▼
2024 · 12.04
Debt
€746k▼
2024 · €749k
Debt ≤ 1 year
€498k▲
2024 · €451k
Debt > 1 year
€248k▼
2024 · €299k
Income taxes
€6k▲
2024 · €6k
Staff costs
€178k▼
2024 · €187k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€833k€831k▼
Fixed assets21/28€286k€266k▼
Tangible fixed assets22/27€40k€19k▼
Plant, machinery and equipment23€303-
Furniture and vehicles24-€188
Other tangible fixed assets26€40k€19k▼
Financial fixed assets28€246k€246k=
Current assets29/58€547k€566k▲
Stocks and contracts in progress3€128k€122k▼
Stocks30/36€128k€122k▼
Amounts receivable within one year40/41€247k€292k▲
Trade receivables40€120k€156k▲
Other amounts receivable41€128k€136k▲
Current investments50/53€5k€5k=
Cash at bank and in hand54/58€137k€143k▲
Deferred charges and accrued income490/1€29k€3k▼
Equity and liabilities
Total equity and liabilities10/49€833k€831k▼
Equity10/15€83k€86k▲
Contributions10/11€12k€12k=
Reserves13€2k€73k▲
Distributable reserves133€2k€73k▲
Profit (loss) carried forward14€69k€0▼
Amounts payable17/49€749k€746k▼
Amounts payable after more than one year17€299k€248k▼
Financial debts170/4€299k€248k▼
Amounts payable within one year42/48€451k€498k▲
Current portion of amounts payable after more than one year42€49k€51k▲
Financial debts43€2k€422▼
Credit institutions430/8€2k€422▼
Trade debts44€254k€281k▲
Suppliers440/4€254k€281k▲
Taxes, remuneration and social security45€35k€29k▼
Taxes450/3€7k€6k▼
Remuneration and social security454/9€28k€23k▼
Other amounts payable47/48€110k€137k▲
Income statement
Code20242025
Remuneration, social security and pensions62€187k€178k▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€21k€21k▲
Other operating charges640/8€1k€1k▼
Gross operating margin9900€305k€290k▼
Operating profit (loss)9901€97k€90k▼
Financial income75/76B€5k€6k▲
Recurring financial income75€3k€6k▲
Non-recurring financial income76B€2k€0▼
Financial charges65/66B€10k€13k▲
Recurring financial charges65€10k€13k▲
Profit (loss) for the period before taxes9903€92k€83k▼
Income taxes67/77€6k€6k▲
Profit (loss) for the period9904€86k€78k▼
Profit (loss) for the period to be appropriated9905€86k€78k▼
Appropriation of the result
Profit (loss) to be appropriated9906€149k€146k▼
Profit (loss) brought forward from the previous period14P€63k€69k▲
Transfer to equity691/2-€71k
To other reserves6921-€71k
Profit to be distributed694/7€80k€75k▼
Directors or managers695€80k€75k▼
Social balance
Average headcount (FTE)90873.02.6▼
The notes to these accounts (27 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
28-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 28 days late
2025
30-09
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema · 61 days late
2024
31-12
Financial
Highest result since 2018net €86k ▲71.9%
Operating result €97k, net result €86k, both a record.
30-08
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema · 30 days late
2023
01-09
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema · 32 days late
2022
26-07
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
31-08
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 31 days late
2020
28-09
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 59 days late
2019
31-12
Financial
Weakest financial yearnet €24k ▼42.3%
Net result drops to €24k, the lowest in the series; recovery starts the following year.
05-08
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 5 days late
2018
29-06
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
20-06
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Hoegaarden · 1 establishment unit since 2005
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Tiensestraat 44A3320 HoegaardenGround area
638 m²
Building footprint
317 m²
Volume, LiDAR
2,049 m³
2 parcels, Flanders · tallest building 10.8 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
APOTHEEK LAMBRECHTS
since 20052.148.956.509
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24041D0311/00F000 | Flanders | 449 m² | 1 · 171 m² | 10.8 m · 2 fl. |
| 24041D0280/00Z000 | Flanders | 189 m² | 1 · 146 m² | 10.6 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteHoegaarden2.148.956.509
Similar companies · same sector, comparable size
VANCOPHAR
BE 0540.905.553
Bierbeek · Eq €86k
Farmajes
BE 0681.788.254
Antwerpen · Eq €86k
PHARMACIE SOPHIE MARCQ
BE 0822.931.370
Morlanwelz · Eq €85k
ANTOINE DERBAUD
BE 0786.472.040
Ham-sur-Heure-Nalinnes · Eq €86k
PHARMACIE DETRY
BE 0427.390.017
Bastogne · Eq €85k
Of 5,223 companies in sector 47730 we hold annual accounts for 3,862. 3,310 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded30-06-2005
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
52310
47740Retail trade
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
52320
Sources
Crossroads Bank for EnterprisesNational Bank · 20 filingsAddress and cadastre registers
Data from official sources, last processed on 18-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
1 entryPhone:016766117